ANCA-associated Goodpasture′s syndrome in a patient with rheumatoid arthritis on penicillamine

Indian Journal of Nephrology

Volumn 22, Issue 1, 2012, Pages 45-47

  Sharma, R ^a   Jain, S ^a   Kher, V ^a  

^a MEDANTA THE MEDICITY   (India)

Author keywords

Antineutrophil cytoplasmic antibody; Goodpasture s syndrome; penicillamine; vasculitis

Indexed keywords

CIPROFLOXACIN; CYCLOPHOSPHAMIDE; METHOTREXATE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE; PREDNISOLONE;

ADULT; ANEMIA; ARTICLE; BACTERIUM CULTURE; CASE REPORT; DRUG DOSE INCREASE; GOODPASTURE SYNDROME; HEMOPTYSIS; HUMAN; HUMAN TISSUE; KIDNEY DYSFUNCTION; MALE; MEDICAL HISTORY; PSEUDOMONAS; PSEUDOMONAS INFECTION; RHEUMATOID ARTHRITIS;

EID: 84861045113     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.83743     Document Type: Article

References (17)

1. Hill HF. Penicillamine in rheumatoid arthritis: Adverse effects. Scand J Rheumatol 1979; 28: 94-9. (Pubitemid 9206272)
2. Sternlieb I, Bennet B, Scheinberg IH. D-Penicillamine-induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med 1975; 82: 673-6.
3. Gibson T, Burry HC, Ogg C. Goodpasture syndrome and D-penicillamine. Ann Intern Med 1976; 84: 100.
4. Matloff DS, Kaplan MM. D-Penicillamine-induced Good-pasture'slike syndrome in primary biliary cirrhosis-Successful treatment with plasmapheresis and immunosuppressives. Gastroenterology 1980; 78: 1046-9. (Pubitemid 10120924)
5. Gavaghan TE, McNaught PJ, Ralston M, Hayes JM. Penicillamineinduced 'Goodpasture's syndrome': Successful treatment of a fulminant case. Aust N Z J Med 1981; 11: 261-5. (Pubitemid 11051913)
6. Gaskin G, Thompson EM, Pusey CD. Goodpasture-like syndrome associated with anti myeloperoxidase antibodies following Penicillamine treatment. Nephrol Dial Transplant 1995; 10: 1925-8.
7. Derk CT, Jimenez SA. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: Report and review of the literature. J Rheumatol 2003; 30: 1616-20. (Pubitemid 36835465)
8. Ross JH, McGinty F, Brewer DG. Penicillamine nephropathy. Nephron 1980; 26: 184-6. (Pubitemid 10048871)
9. Bienaimé F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP. D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am J Kidney Dis 2007; 50: 821-5. (Pubitemid 47588548)
10. Nanke Y, Akama H, Terai C, Kamatani N. Rapidly progressive glomerulonephritis with D-penicillamine. Am J Med Sci 2000; 320: 398-402. (Pubitemid 32046958)
11. Falk RJ, Jennette CJ. ANCA with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-7.
12. Cuperus RA, Muijsers AO, Wever R. Antiarthritic drugs containing thiol groups scavenge hypochlorite and inhibit its formation by myeloperoxidase from human leukocytes (A therapeutic mechanism of these drugs in rheumatoid arthritis?). Arthritis Rheum 1985; 28: 1228-33. (Pubitemid 16214074)
13. Goldman M, Druet P, Gleichmann E. TH2 cells in systemic autoimmunity: Insights from allogeneic diseases and chemicallyinduced autoimmunity. Immunol Today 1991; 12: 223-7.
14. PeterHH, Metzger D, Rump A, Rother E. ANCA in disease other than systemic vasculitis. Clin Exp Immunol 1993; 92: 12-4. (Pubitemid 23276685)
15. Walshe J. Penicillamine and the SLE syndrome. J Rheumatol 1981; 8: 155-60. (Pubitemid 11108139)
16. Cameron J. Lupus nephritis. J Am Soc Nephrol 1999; 10: 413-24. (Pubitemid 29068083)
17. Short AK, Lockwood CM. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. QJ Med 1995; 88: 775-83.